Zhe Yu

453 total citations
25 papers, 357 citations indexed

About

Zhe Yu is a scholar working on Immunology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Zhe Yu has authored 25 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Molecular Biology and 8 papers in Biomedical Engineering. Recurrent topics in Zhe Yu's work include RNA Interference and Gene Delivery (8 papers), Immunotherapy and Immune Responses (8 papers) and Nanoparticle-Based Drug Delivery (5 papers). Zhe Yu is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Immunotherapy and Immune Responses (8 papers) and Nanoparticle-Based Drug Delivery (5 papers). Zhe Yu collaborates with scholars based in China, Hong Kong and United Kingdom. Zhe Yu's co-authors include Qingyu Fan, Minghua Zhang, Tiehong Yang, Hong Wu, Xin He, Jie Geng, Jingyuan Chen, Yong Zhou, Baoan Ma and Youbei Qiao and has published in prestigious journals such as Chemical Communications, International Journal of Radiation Oncology*Biology*Physics and Molecules.

In The Last Decade

Zhe Yu

23 papers receiving 354 citations

Peers

Zhe Yu
Comparison fields: 5 of 81
  • Immunology 113
  • Molecular Biology 101
  • Oncology 93
  • Biomaterials 75
  • Biomedical Engineering 70
Replace Yuefei Fang with:
Yuefei Fang China
Manxiu Huai China
Yanfang Wang China
Jiayu Zhang China
Tiep Tien Nguyen South Korea
HoYin Lip Canada
Maryam Heidarifard Iran
Leilei Yang China
Chunjuan Zheng China
Maryam Ebrahimi Nik Iran
Yuefei Fang China View profile →
Citations per field, relative to Zhe Yu
Zhe Yu · 1×
Citations per year, relative to Zhe Yu
Zhe Yu · 1×

Countries citing papers authored by Zhe Yu

Since Specialization
Citations

This map shows the geographic impact of Zhe Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhe Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhe Yu more than expected).

Fields of papers citing papers by Zhe Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhe Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhe Yu. The network helps show where Zhe Yu may publish in the future.

Co-authorship network of co-authors of Zhe Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhe Yu. A scholar is included among the top collaborators of Zhe Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhe Yu. Zhe Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 5
3 0
4 9
5 13
6 18
7 37
8 12
9 7
10 27
11 23
12 9
13 1
14 7
15 11
16 11
17 35
18 15
19 2
20
Specific antitumor effects of tumor vaccine produced by electrofusion between osteosarcoma cell and dendritic cell in rats.
8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026